295 related articles for article (PubMed ID: 11180885)
21. Histological features and interphase nucleolar organizer regions in hyperplastic, dysplastic and neoplastic epithelium of intrahepatic bile ducts in hepatolithiasis.
Terada T; Nakanuma Y; Ohta T; Nagakawa T
Histopathology; 1992 Sep; 21(3):233-40. PubMed ID: 1328014
[TBL] [Abstract][Full Text] [Related]
22. Histopathological evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma.
Bhalla A; Mann SA; Chen S; Cummings OW; Lin J
Hum Pathol; 2017 Sep; 67():217-224. PubMed ID: 28823571
[TBL] [Abstract][Full Text] [Related]
23. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
24. Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis.
Miyazaki T; Shinkawa H; Takemura S; Tanaka S; Amano R; Kimura K; Ohira G; Nishio K; Kinoshita M; Tsuchi J; Ishihara A; Eguchi S; Shirai D; Yamamoto T; Wakasa K; Kawada N; Kubo S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3647-3654. PubMed ID: 33369464
[TBL] [Abstract][Full Text] [Related]
25. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
26. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.
Nguyen Canh H; Harada K
Med Mol Morphol; 2016 Dec; 49(4):189-202. PubMed ID: 27350291
[TBL] [Abstract][Full Text] [Related]
27. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
Torbenson M; Yeh MM; Abraham SC
Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
[TBL] [Abstract][Full Text] [Related]
28. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
[TBL] [Abstract][Full Text] [Related]
29. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma.
Terada T; Ueyama J; Ukita Y; Ohta T
Liver; 2000 Dec; 20(6):450-7. PubMed ID: 11169059
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
[TBL] [Abstract][Full Text] [Related]
31. [Primary cholangiocarcinoma in a case of Caroli's disease: case report and literature review].
Kasper HU; Stippel DL; Töx U; Drebber U; Dienes HP
Pathologe; 2006 Jul; 27(4):300-4. PubMed ID: 16775675
[TBL] [Abstract][Full Text] [Related]
32. Bile duct changes in different etiologic types of end-stage chronic liver disease: a study on native explant livers.
Jain D; Nayak NC
J Clin Pathol; 2012 Apr; 65(4):348-51. PubMed ID: 22135029
[TBL] [Abstract][Full Text] [Related]
33. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection.
Joo I; Lee JM
Abdom Imaging; 2013 Dec; 38(6):1334-50. PubMed ID: 23925840
[TBL] [Abstract][Full Text] [Related]
34. Expression of MAGE-A3 in intrahepatic cholangiocarcinoma and its precursor lesions.
Tsuneyama K; Sasaki M; Shimonishi T; Nakanuma Y
Pathol Int; 2004 Mar; 54(3):181-6. PubMed ID: 14989741
[TBL] [Abstract][Full Text] [Related]
35. Cholangiocarcinoma: lessons from Thailand.
Sripa B; Pairojkul C
Curr Opin Gastroenterol; 2008 May; 24(3):349-56. PubMed ID: 18408464
[TBL] [Abstract][Full Text] [Related]
36. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
[TBL] [Abstract][Full Text] [Related]
37. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
Seo N; Kim DY; Choi JY
AJR Am J Roentgenol; 2017 Aug; 209(2):W64-W75. PubMed ID: 28570102
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
39. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions.
Yeh TS; Tseng JH; Chen TC; Liu NJ; Chiu CT; Jan YY; Chen MF
Hepatology; 2005 Sep; 42(3):657-64. PubMed ID: 16116640
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus and intrahepatic cholangiocarcinoma.
Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
